Trial results
$DMAC — DM199
DiaMedica Therapeutics Inc. (DMAC) DM199: trial results in Acute ischemic stroke, 2027.
The catalyst
"ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial Surpasses 200-Participant Enrollment Threshold; Interim Analysis Expected Q1 2027"
— DiaMedica Therapeutics, 8-K filed 2026-11-12 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.
- Event id
DMAC-DM199-2026- Company
- DiaMedica Therapeutics Inc.
- Kind
- Trial results
- Indication
- Acute ischemic stroke
- Window
- 2027-01-01 – 2027-03-31
- Status
- dropped
The bar
No bar has been published for this event yet.
Verdicts
No verdict has been published for this event yet.